Suppr超能文献

三伏九治疗过敏的疗效:治疗 1 年后患者的结局。

Efficacy of Sanfujiu to treat allergies: patient outcomes at 1 year after treatment.

机构信息

Department of Traditional Chinese Medicine, Taipei Medical University Hospital, Taipei, Taiwan.

出版信息

Evid Based Complement Alternat Med. 2007 Jun;4(2):241-6. doi: 10.1093/ecam/nel082. Epub 2006 Nov 24.

Abstract

Sanfujiu is a treatment method of applying herbal paste onto the acupoints Fengmen and Feishu during the three hottest days of summer to treat patients with allergies. The objectives of this study were to determine the treatment efficacy at 1 year after the Sanfujiu treatment, and examine variations in the perceived efficacy of Sanfujiu among different subgroups, based on the patients' ages, diagnoses and number of reactive symptoms immediately after the treatment. We enrolled 105 patients who completed Sanfujiu treatment at a medical university hospital in Taipei as the subjects. One year after treatment, trained interviewers conducted telephone interviews with the patients. Approximately 60% of them perceived the treatment as being effective at 1 year later, which was higher than that at 1 week after treatment (45.7%). Younger subjects (<19 years of age) and patients with asthma were more likely to report the treatment as being effective. Patients who had more reactive symptoms after the third Sanfujiu treatment were more likely to report the treatment as being effective. The results demonstrated that Sanfujiu was moderately effective, as perceived by patients in Taiwan, in treating their allergic symptoms.

摘要

三伏九贴是一种在夏季三伏天应用草药贴敷于风门和肺俞穴位的治疗方法,用于治疗过敏患者。本研究旨在确定三伏九贴治疗 1 年后的疗效,并根据患者治疗后即刻的年龄、诊断和反应症状数量,考察三伏九贴疗效在不同亚组之间的变化。我们招募了在台北某医科大学附属医院完成三伏九贴治疗的 105 例患者作为研究对象。治疗 1 年后,经过培训的访视员对患者进行电话访谈。大约 60%的患者在 1 年后认为治疗有效,高于治疗后 1 周时的 45.7%。年轻的患者(<19 岁)和哮喘患者更有可能报告治疗有效。第三次三伏九贴治疗后反应症状较多的患者更有可能报告治疗有效。结果表明,在台湾,患者认为三伏九贴治疗其过敏症状的效果中等。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3c5/1876606/f248abb4c86e/nel082f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验